BIOLASE Reports Unaudited Revenue Growth for Full Year 2023 and Provides Outlook for Full Year 2024
Dentistry Today
JANUARY 29, 2024
NASDAQ: BIOL), the global leader in dental lasers, announced preliminary unaudited revenue results for 2023 based on currently available information and expects to report year-over-year growth as it continues to generate interest among dental practitioners for its industry-leading lasers. BIOLASE, Inc. million to $49.2
Let's personalize your content